Advertisement

Acetazolamide Injection

[27 March 2015]

Products Affected - Description

Acetazolamide injection, Sagent
500 mg vial, single-count (NDC 25021-0817-10)

Reason for the Shortage

  • West-Ward Pharmaceuticals’ parent company, Hikma Pharmaceuticals, acquired acetazolamide injection from Bedford in July 2014. West-Ward is not actively marketing acetazolamide injection at this time.
  • Sagent has acetazolamide injection on shortage due to manufacturing delay.

Available Products

500 mg vial, single-count (NDC 39822-0190-01)
500 mg Novaplus vial, single-count (NDC 39822-0190-07)

Estimated Resupply Dates

Sagent has acetazolamide injection on back order and the company estimates a release date of June 2015.

Related Shortages

Updated

March 18 and 27, January 16, 2015; December 22, November 12, August 27, June 5, March 17, 2014; December 17, October 14, August 13, June 11, April 29, March 7, January 14 and 22, 2013; October 30, August 22, June 20, April 11, February 7, 2012; November 8 and 21, September 16, July 1 and 22, May 26, March 11, January 25, 2011; December 14, November 8, October 19, September 14, August 17, 2010, University of Utah, Drug Information Service. Copyright 2015, University of Utah, Drug Information Service.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement